XML 22 R10.htm IDEA: XBRL DOCUMENT

Marketable Securities	9 Months Ended
Marketable Securities	Sep. 30, 2025
Investments, Debt and Equity Securities [Abstract]
Marketable Securities	Marketable Securities The Company's marketable securities are classified as available-for-sale pursuant to ASC 320, Investments – Debt and Equity Securities and are recorded at fair value. Unrealized gains (losses) are included as a component of accumulated other comprehensive loss in the condensed consolidated balance sheets and statements of stockholders’ equity and a component of total comprehensive loss in the condensed consolidated statements of comprehensive loss, until realized. The Company assesses its available-for-sale marketable securities for impairment on a quarterly basis. The Company's marketable securities portfolio historically contains investments in U.S. Treasury, other U.S. government-backed securities, and commercial paper. The Company reviews its portfolio based on the underlying risk profile of the securities and does not expect there to be a loss on these investments. The Company also regularly reviews the securities in an unrealized loss position and evaluates the current expected credit loss by considering factors such as historical experience, market data, issuer-specific factors, and current economic conditions. There were no marketable securities as of September 30, 2025 and December 31, 2024, respectively. There were no impairments recorded during the three and nine months ended September 30, 2025 or September 30, 2024. Realized gains and losses are included in other income (expense) on the condensed consolidated statements of operations. During the three and nine months ended September 30, 2025 and 2024, the Company recognized no year-to-date credit loss related to its short-term investments, and had no allowance for credit loss recorded as of September 30, 2025 or December 31, 2024.